AriBioLab Co.,Ltd. (KOSDAQ:261780)
South Korea · Delayed Price · Currency is KRW 2,380.00
-140.00 (-5.56%)
At close: Jul 20, 2026
AriBioLab Market Cap
AriBioLab has a market cap or net worth of 63.51 billion as of July 21, 2026. Its market cap has decreased by -25.42% in one year.
Market Cap
63.51B
Enterprise Value
53.30B
Revenue
331.78M
Ranking
n/a
PE Ratio
n/a
Stock Price
2,380.00
ChartMarket Cap Chart
Since October 22, 2021, AriBioLab's market cap has decreased from 343.58B to 63.51B, a decrease of -81.51%. That is a compound annual growth rate of -29.92%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 63.51B | -16.31% |
| Dec 30, 2025 | 75.89B | -7.54% |
| Dec 30, 2024 | 82.08B | -45.65% |
| Dec 28, 2023 | 151.04B | 14.64% |
| Dec 29, 2022 | 131.75B | -55.09% |
| Dec 30, 2021 | 293.36B | -14.62% |
| Oct 22, 2021 | 343.58B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BIO-FD&C | 71.39B |
| SunBio,Inc. | 69.75B |
| QuadMedicine | 68.20B |
| CTCBIO | 67.90B |
| EyeGene | 64.11B |
| PanGen Biotech | 61.69B |
| KoBioLabs | 59.81B |
| ABION | 58.12B |